Vasotec: Advanced Blood Pressure Control for Cardiovascular Health
Vasotec
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.00 (0%) | 🛒 Add to cart |
| 90 | $0.72 | $73.50 $65.00 (12%) | 🛒 Add to cart |
| 120 | $0.68 | $98.00 $81.00 (17%) | 🛒 Add to cart |
| 180 | $0.63 | $147.00 $113.00 (23%) | 🛒 Add to cart |
| 270 | $0.60 | $220.50 $161.00 (27%) | 🛒 Add to cart |
| 360 | $0.57
Best per pill | $294.00 $207.00 (30%) | 🛒 Add to cart |
Vasotec (enalapril maleate) is an angiotensin-converting enzyme (ACE) inhibitor medication clinically proven to manage hypertension and improve heart function. This prescription medication works by relaxing blood vessels, allowing blood to flow more smoothly and reducing strain on the cardiovascular system. Trusted by healthcare professionals for decades, Vasotec represents a cornerstone therapy in modern cardiovascular care with well-established efficacy and safety profiles.
Features
- Contains enalapril maleate as the active pharmaceutical ingredient
- Available in multiple tablet strengths (2.5 mg, 5 mg, 10 mg, 20 mg)
- Once or twice-daily dosing regimen for patient convenience
- FDA-approved for hypertension and heart failure treatment
- Demonstrated renal protective effects in diabetic patients
- Compatible with many other cardiovascular medications
Benefits
- Effectively lowers high blood pressure to reduce cardiovascular risk
- Decreases workload on the heart in patients with heart failure
- Slows progression of kidney disease in diabetic patients
- Reduces hospitalization rates for heart failure exacerbations
- Improves survival rates following heart attacks
- Provides 24-hour blood pressure control with consistent dosing
Common use
Vasotec is primarily prescribed for the management of hypertension (high blood pressure) in adults. It is also indicated for the treatment of symptomatic heart failure, often in combination with diuretics and digitalis. Additionally, physicians may prescribe Vasotec for patients with left ventricular dysfunction following myocardial infarction to improve survival and reduce hospitalization. The medication has established benefits in delaying the progression of renal disease in hypertensive patients with diabetes and proteinuria.
Dosage and direction
The recommended initial dosage for hypertension is 5 mg once daily in patients not taking diuretics. Dosage may be increased to a maintenance dose of 10-40 mg administered once or divided into two doses. For heart failure, therapy is usually initiated at 2.5 mg once daily under close medical supervision. Dosage should be individualized based on blood pressure response and tolerability. Tablets should be swallowed whole with water, with or without food, at approximately the same time each day. Patients should not abruptly discontinue therapy without consulting their healthcare provider.
Precautions
Patients should undergo assessment of renal function and electrolytes before initiating therapy. Blood pressure monitoring is essential during dosage adjustments. Caution is advised in patients with impaired renal function, collagen vascular disease, or those taking immunosuppressive therapy due to increased risk of neutropenia/agranulocytosis. Vasotec may cause symptomatic hypotension, particularly in volume-depleted patients. Regular monitoring of white blood cell counts is recommended in patients with pre-existing renal impairment or collagen vascular disease. Angioedema may occur at any time during treatment.
Contraindications
Vasotec is contraindicated in patients with a history of angioedema related to previous ACE inhibitor treatment. It should not be used in patients with hereditary or idiopathic angioedema. The medication is contraindicated in combination with aliskiren in patients with diabetes. Do not use during the second and third trimesters of pregnancy due to potential fetal harm. Concomitant use with sacubitril/valsartan is contraindicated due to increased risk of angioedema.
Possible side effect
Common side effects may include dizziness (2-8%), headache (2-5%), fatigue (2-3%), and cough (1-2%). Less frequently, patients may experience orthostatic hypotension, rash, nausea, or hyperkalemia. Rare but serious adverse effects include angioedema, neutropenia/agranulocytosis, hepatic failure, and renal impairment. The characteristic dry, persistent cough associated with ACE inhibitors typically resolves upon discontinuation of therapy. Most side effects are dose-dependent and may diminish with continued treatment.
Drug interaction
Vasotec may interact with diuretics, potentiating hypotensive effects. Concurrent use with potassium-sparing diuretics, potassium supplements, or salt substitutes containing potassium may increase risk of hyperkalemia. Nonsteroidal anti-inflammatory drugs (NSAIDs) may diminish the antihypertensive effect and increase risk of renal impairment. Lithium levels may increase when co-administered with Vasotec. Dual blockade of the renin-angiotensin system with ARBs or aliskiren increases risks of hypotension, hyperkalemia, and renal impairment.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Patients should not double the dose to make up for a missed one. Consistent dosing is important for maintaining stable blood pressure control. If multiple doses are missed, patients should contact their healthcare provider for guidance on resuming therapy.
Overdose
Symptoms of overdose may include severe hypotension, bradycardia, circulatory shock, electrolyte disturbances, and renal failure. Management involves supportive care including volume expansion with normal saline to restore blood pressure. Hemodialysis may be effective in removing enalaprilat, the active metabolite. Vasopressor therapy may be necessary in cases of profound hypotension. Patients suspected of overdose should receive immediate medical attention with continuous monitoring of vital signs and electrolyte status.
Storage
Store Vasotec tablets at controlled room temperature (20-25°C or 68-77°F) with excursions permitted between 15-30°C (59-86°F). Keep the medication in its original container, tightly closed, and protected from light and moisture. Keep out of reach of children and pets. Do not use tablets that appear discolored or show signs of deterioration. Properly discard any unused medication after the expiration date printed on the packaging.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Vasotec is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Individual results may vary. Patients should not make changes to their medication regimen without consulting their physician. The complete prescribing information should be reviewed before initiating therapy.
Reviews
Clinical studies demonstrate Vasotec’s efficacy in reducing blood pressure by approximately 8-12/5-8 mmHg in hypertensive patients. In heart failure trials, Vasotec significantly reduced mortality and hospitalization rates compared to placebo. Long-term follow-up studies show sustained antihypertensive effects with maintained tolerability profile. Many patients report improved quality of life and better exercise tolerance with appropriate dosing. Healthcare providers consistently rate Vasotec as a reliable first-line option for hypertension management with proven cardiovascular and renal protective benefits.